Grant: Engage Grants Program
Université de Sherbrooke
$25,000.00
Validation of cell impedance sensing as a high-throughput approach for toxicity evaluation in vitro
FY 2017-18
Summary
As a world leader in the field of toxicology, Charles River Laboratories (CRL) is seeking to expand itsportfolio of toxicology expertises through the development of novel cell-based assays. In this project, wepropose to apply electric cell impedance sensing (ECIS) for the evaluation of functional end-point associatedwith two critical parameters of homeostasis, that is endothelium permeability and platelet aggregation.Endothelial cells and platelets play pivotal roles in homeostasis and thrombosis and it has become clear thatvascular safety of drugs constitutes an important criterion in both the drug development and the drug approvalprocesses. Drug-induced endothelium leakage is routinely tested in animal models by measuring Evans Blueendothelium extravasation in organs. Platelet function can be evaluated ex vivo using light transmissionaggregation assay or by impedance aggregometry which measure platelet adhesion on a pair of electrodeimmersed in a whole blood sample. Although very simple and sensitive, theses two standardised in vivoprocedures are very low throughput in nature, which makes them rapidly unpractical and expensive if one aimsat establishing dose-toxicity curves early in the selection of promising lead candidates from compoundlibraries. To address this limitation, we will validate two cell-based assays using an electrical impedancetechnology in 96-well format to quantify drugs-induced endothelium permeability and platelet aggregation.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
518251-2017
Name nom
Grandbois, Michel
Department département
Pharmacologie-physiologie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
6403
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Toxicology
Research subject fr
Toxicologie
Partie
1
Nb partie
1
Application title
Validation of cell impedance sensing as a high-throughput approach for toxicity evaluation in vitro
Keyword
NSERC
Application summary
As a world leader in the field of toxicology, Charles River Laboratories (CRL) is seeking to expand itsportfolio of toxicology expertises through the development of novel cell-based assays. In this project, wepropose to apply electric cell impedance sensing (ECIS) for the evaluation of functional end-point associatedwith two critical parameters of homeostasis, that is endothelium permeability and platelet aggregation.Endothelial cells and platelets play pivotal roles in homeostasis and thrombosis and it has become clear thatvascular safety of drugs constitutes an important criterion in both the drug development and the drug approvalprocesses. Drug-induced endothelium leakage is routinely tested in animal models by measuring Evans Blueendothelium extravasation in organs. Platelet function can be evaluated ex vivo using light transmissionaggregation assay or by impedance aggregometry which measure platelet adhesion on a pair of electrodeimmersed in a whole blood sample. Although very simple and sensitive, theses two standardised in vivoprocedures are very low throughput in nature, which makes them rapidly unpractical and expensive if one aimsat establishing dose-toxicity curves early in the selection of promising lead candidates from compoundlibraries. To address this limitation, we will validate two cell-based assays using an electrical impedancetechnology in 96-well format to quantify drugs-induced endothelium permeability and platelet aggregation.